Differential behavioral effects of TFF peptides injections of synthetic TFF3 into the rat amygdala

Pharmacology Biochemistry and Behavior

Volumn 62, Issue 1, 1999, Pages 173-178

  Schwarzberg, Helmut ^a   Kalbacher, Hubert ^b   Hoffmann, Werner ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b Medizinisch N   (Germany)

Author keywords

Amygdala; Anxiogenic; Anxiolytic; Elevated plus maze; Fear; Hypothalamus; Locomotor activity; Passive avoidance response; TFF domain

Indexed keywords

TREFOIL PEPTIDE;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DOSE RESPONSE; INTRACEREBRAL DRUG ADMINISTRATION; LOCOMOTION; MALE; NONHUMAN; PASSIVE AVOIDANCE; PRIORITY JOURNAL; RAT;

AMYGDALA; ANIMALS; AVOIDANCE LEARNING; GROWTH SUBSTANCES; INJECTIONS, INTRAVENOUS; MALE; MAZE LEARNING; MOTOR ACTIVITY; MUCINS; MUSCLE PROTEINS; NEUROPEPTIDES; PEPTIDES; RATS; RATS, WISTAR;

LOTUS;

EID: 0032906871     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(98)00137-3     Document Type: Article

References (36)

1. Ader R., Weijnen J.A.W.M., Moleman P. Retention of a passive avoidance response as a function of the intensity and duration of electric shock. Psychon. Sci. 26:1972;125-128.
2. Bernstein H.-G., Schwarzberg H., Poeggel G., Reiser M. Intracerebroventricular but not intraperitoneal administration of aluminum attenuates vasopressin-enhanced retrieval of a passive avoidance task in rats. Pharmacol. Biochem. Behav. 47:1994;587-590.
3. Bohus B., Kovács G.L., De Wied D. Oxytocin, vasopressin and memory. Opposite effects on consolidation and retrieval processes Brain Res. 157:1978;414-417.
4. Bucherelli C., Tassoni G., Bures B. Time-dependent disruption of passive avoidance acquisition by post-training intra-amygdala injection of tetrodotoxin in rats. Neurosci. Lett. 140:1992;231-234.
5. Chopin P., Briley M. Animal models of anxiety. The effect of compounds that modify 5-HT neurotransmission Trends Pharmacol. Sci. 8:1987;383-388.
6. D'Amour F.E., Smith D.L. A method for determining loss of pain sensation. J. Pharmacol. Exp. Ther. 72:1941;74-79.
7. Davis M. The role of the amygdala in emotional learning. Int. Rev. Neurobiol. 36:1994;225-266.
8. Dawson G.R., Crawford S.P., Collinson N., Iversen S.D., Tricklebank M.D. Evidence that the anxiolytic-like effects of chlordiazepoxide on the elevated plus maze are confounded by increases in locomotor activity. Psychopharmacology (Berlin). 118:1995;316-323.
9. Dawson G.R., Tricklebank M.D. Use of the elevated plus maze in the search for novel anxiolytic agents. Trends Pharmacol. Sci. 16:1995;33-37.
10. Dignass A., Lynch-Denaney K., Kindon H., Thim L., Podolsky D.K. Trefoil peptides promote epithelial migration through a transforming growth factor β-independent pathway. J. Clin. Invest. 94:1994;376-383.
11. Hoffmann W., Hauser F. The P-domain or trefoil motif. a role in renewal and pathology of mucous epithelia? Trends Biochem. Sci. 18:1993;239-243.
12. Hirota M., Awatsuji H., Furukawa Y., Hayashi K. Cytokine regulation of pS2 gene expression in mouse astrocytes. Biochem. Mol. Biol. Int. 33:1994;515-520.
13. Hirota M., Awatsuji H., Sugihara Y., Miyashita S., Furukawa Y., Hayashi K. Expression of pS2 gene in rat brain. Biochem. Mol. Biol. Int. 35:1995;1079-1084.
14. Hirota M., Miyashita S., Hayashi H., Furukawa Y., Hayashi K. pS2 gene especially expressed in the late G1/S phase of mouse astrocytes. Neurosci. Lett. 171:1994;49-51.
15. Introini-Collison I.B., Ford L., McGaugh J.L. Memory impairment induced by intraamygdala β-endorphin is mediated by noradrenergic influences. Neurobiol. Learn. Mem. 63:1995;200-205.
16. Kovács G.L., De Wied D. Peptidergic modulation of learning and memory processes. Pharmacol. Rev. 46:1994;269-291.
17. Kropshofer H., Max H., Müller C.A., Hesse F., Stevanovic S., Jung G., Kalbacher H. Self-peptide released from class II HLA-DR1 exhibits a hydrophobic two-residue contact motif. J. Exp. Med. 175:1992;1799-1803.
18. LeDoux J.E. Emotion. Clues from the brain Annu. Rev. Psychol. 46:1995;209-235.
19. Lefebvre O., Chenard M.-P., Masson R., Linares J., Dierich A., LeMeur M., Wendling C., Tomasetto C., Chambon P., Rio M.-C. Gastric mucosa abnormalities and tumorigenesis in mice lacking the pS2 trefoil protein. Science. 274:1996;259-262.
20. Lu Y.-F., Moriwaki A., Hayashi Y., Tomizawa K., Itano T., Matsui H. Effects of neurotensin on neurons in the rat central amygdaloid nucleus in vitro. Brain Res. Bull. 40:1996;135-141.
21. Mashimo H., Wu D.-C., Podolsky D.K., Fishman M.C. Impaired defense of intestinal mucosa in mice lacking intestinal trefoil factor. Science. 274:1996;262-265.
22. McKernan M.G., Shinnik-Gallagher P. Fear conditioning induces a lasting potentiation of synaptic currents in vitro. Nature. 390:1997;607-611.
23. Moser P.C. An evaluation of the elevated plus-maze test using the novel anxiolytic buspirone. Psychopharmacology (Berlin). 99:1989;48-53.
24. Pawelec G., Max H., Halder T., Bruserud O., Merl A., da Silva P., Kalbacher H. BCR/ABL leukemia oncogene fusion peptides selectively bind to certain HLA-DR alleles and can be recognized by T cells found at low frequency in the repertoire of normal donors. Blood. 88:1996;2118-2124.
25. Paxinos G., Watson C. The rat brain in stereotaxic coordinates. 1986;Academic Press, San Diego.
26. Pellow S., Chopin P., File S.E., Briley M. Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J. Neurosci. Methods. 14:1985;149-167.
27. Playford R.J., Marchbank T., Chinery R., Evison R., Pignatelli M., Boulton R.A., Thim L., Hanby A.M. Human spasmolytic polypeptide is a cytoprotective agent that stimulates cell migration. Gastroenterology. 108:1995;108-116.
28. Probst J.C., Skutella T., Müller-Schmid A., Jirikowski G.F., Hoffmann W. Molecular and cellular analysis of rP1.B in the rat hypothalamus. In situ hybridization and immunohistochemistry of a new P-domain neuropeptide Mol. Brain Res. 33:1995;269-276.
29. Roberts G.W. Neuropeptides. Cellular morphology, major pathways, and functional considerations Aggleton J.P. The amygdala. Neurobiological aspects of emotion, memory, and mental dysfunction:1992;115-142 Wiley-Liss, New York.
30. Rodgers R.J., Dalvi A. Anxiety, defence and the elevated plus-maze. Neurosci. Biobehav. Rev. 21:1997;801-810.
31. Rogan M.Z., Stäubli U.V., LeDoux J.E. Fear conditioning induces associative long-term potentiation in the amygdala. Nature. 390:1997;604-607.
32. Sanford L.D., Tejani-Butt S.M., Ross R.J., Morrison A.R. Amygdaloid control of alerting and behavioral arousal in rats. Involvement of serotonergic mechanisms Arch. Ital. Biol. 134:1995;81-99.
33. Tan X.-D., Hsueh W., Chang H., Wei K.-R., Gonzalez-Crussi F. Characterization of a putative receptor for intestinal trefoil factor in rat intestine. Identification by in situ binding and ligand blotting Biochem. Biophys. Res. Commun. 237:1997;673-677.
34. Veldhuis H.D., De Wied D. Differential behavioral actions of corticotrophin-releasing factor (CRF). Pharmacol. Biochem. Behav. 21:1984;707-713.
35. Weyers P., Fritze J. Tiermodelle der Angst. Kasper S., Möller H.-J. Angst- und Panikerkrankungen. 1995;233-269 Gustav Fischer Verlag, Jena, Stuttgart.
36. Wright N.A., Hoffmann W., Otto W.R., Rio M.-C., Thim L. Rolling in the clover. The trefoil factor family (TFF)-domain peptides, cell migration and cancer FEBS Lett. 408:1997;121-123.